HORIZON KINETICS ASSET MANAGEMENT LLC

Position in BEAM — Beam Therapeutics Inc.

CIK 1056823 NEW YORK, NY

Position in BEAM

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$287,876

+$78,387 QoQ

Shares Held

8,388

-4.6% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#175

of 276 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HORIZON KINETICS ASSET MANAGEMENT LLC holds $23,045,365 across 14 Biotechnology names. BEAM ranks #6 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	344,861	$19,336,356
2	IONS	Ionis Pharmaceuticals Inc	10,904	$864,578
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,168	$652,633
4	CRSP	CRISPR Therapeutics AG	9,353	$510,112
5	REGN	Regeneron Pharmaceuticals, Inc.	645	$402,183
6	BEAM	Beam Therapeutics Inc. This page	8,388	$287,876
7	GALT	Galectin Therapeutics Inc	46,968	$217,931
8	NTLA	Intellia Therapeutics, Inc.	12,584	$212,921

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$287,876	8,388	-4.6%	Shares	Defined	2026-08-11
2026-03-31	$209,489	8,791	-4.4%	Shares	Defined	2026-05-15
2025-12-31	$254,857	9,194	-4.2%	Shares	Defined	2026-02-11
2025-09-30	$232,919	9,597	0.0%	Shares	Defined	2025-11-14
2024-12-31	$238,005	9,597	+4.4%	Shares	Defined	2025-02-10
2024-09-30	$225,253	9,194	-4.2%	Shares	Defined	2024-11-13
2024-06-30	$224,857	9,597	0.0%	Shares	Defined	2024-08-14
2024-03-31	$317,084	9,597	0.0%	Shares	Defined	2024-05-14
2023-12-31	$261,230	9,597	-4.0%	Shares	Defined	2024-02-15
2023-09-30	$240,500	10,000	0.0%	Shares	Defined	2023-11-14
2023-06-30	$319,300	10,000	0.0%	Shares	Defined	2023-08-14
2023-03-31	$306,200	10,000	—	Shares	Defined	2023-05-12
No filing history on record for this holder in this stock.